U.S. Markets for Vaccines
Characteristics, Case Studies, and Controversies

  • Title:

    U.S. Markets for Vaccines
  • Format:

    Paperback
  • Paperback Price:

    20.00
  • Paperback ISBN:

    978-0-8447-4280-9
  • Paperback Dimensions:

    6" x 9"
  • 248 Paperback pages
  • Buy the Book

Click here to view the full text as an Adobe PDF.

There is intense interest among scholars and the public about the risks, benefits, and pricing of pharmaceuticals--but relatively little attention has been devoted to vaccine markets and the political, economic, and regulatory factors that influence their development. In this important new study, Ernst R. Berndt, Rena N. Denoncourt, and Anjli C. Warner investigate the key business drivers and challenges of vaccine markets, the complex interactions among their important stakeholders, and the emerging opportunities for growth.

U.S. Markets for Vaccines: Characteristics, Case Studies, and Controversies examines several case studies--including vaccines for diphtheria, tetanus, pertussis, seasonal influenza, chicken pox, and shingles--that demonstrate the diverse dynamics of vaccine markets. The authors consider the role of intellectual property protection in the discovery process, preclinical and clinical development issues, manufacturing and cost characteristics, and the challenges of marketing, product differentiation, pricing, and distribution. They also explore the process of obtaining regulatory approval from the U.S. Food and Drug Administration and earning a spot on the Centers for Disease Control and Prevention's vaccination schedules for pediatric and adult populations. Finally, the authors address the controversial debate over an alleged link between childhood vaccinations and autism.

Drawing upon extensive interviews with representatives from industry, insurance providers, government agencies, health-care providers, and academia, U.S. Markets for Vaccines offers a balanced and comprehensive snapshot of the changing landscape for vaccine markets.

Ernst R. Berndt, PhD, is the Louis E. Seley Professor in Applied Economics at the MIT Sloan School of Management, and a member of the affiliated faculty of the Harvard-MIT Division of Health Sciences and Technology.

Rena N. Denoncourt, MBA, is program manager at Alnylam Pharmaceuticals in Cambridge, Massachusetts.

Anjli C. Warner, MBA, is senior associate, Business Analysis and Information, Amgen, Thousand Oaks, California.

 

 

 

Also Visit
AEIdeas Blog The American Magazine

What's new on AEI

Making Ryan's tax plan smarter
image The teacher evaluation confronts the future
image How to reform the US immigration system
image Inversion hysteria
AEI on Facebook
Events Calendar
  • 25
    MON
  • 26
    TUE
  • 27
    WED
  • 28
    THU
  • 29
    FRI
Wednesday, August 27, 2014 | 3:00 p.m. – 4:15 p.m.
Teacher quality 2.0: Toward a new era in education reform

Please join AEI for a conversation among several contributors to the new volume “Teacher Quality 2.0: Toward a New Era in Education Reform” (Harvard Education Press, 2014), edited by Frederick M. Hess and Michael Q. McShane. Panelists will discuss the intersection of teacher-quality policy and innovation, exploring roadblocks and possibilities.

No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled today.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.